Weak retail sales and falls in key oil and drug stocks stifle FTSE 100 The FTSE 100 index closed down 17.15 points, 0.2%, at 8,774.65. Evening Standard · Jun 20, 2025
From AI to aerospace: Europe's most innovative companies shaping tomorrow For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the standouts that are driving progress with success. Fortune · Jun 12, 2025
Queens of influence: Meet the women shaping Europe's future In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the helm of European companies. Fortune · May 23, 2025
The UK is rolling out a world-first vaccine for gonorrhoea. What about the rest of Europe? The UK will offer a vaccine originally intended to prevent meningitis, which is caused by a bacteria with a similar genetic profile to the one that causes gonorrhoea. Euronews · May 22, 2025
British boss of US healthcare giant UnitedHealth quits for ‘personal reasons’ The move comes five months after one of the company’s top executives was killed after being shot as he walked to an investor conference in New York. Evening Standard · May 13, 2025
Tariff turmoil prompts cloudy forecasts from companies for the year ahead Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely shaken by a stark shift in U.S. policy The Independent UK · Apr 30, 2025
Wall Street falls while FTSE 100 regains losses after US economy shrinks The American economy contracted by 0.3% in the first three months of the year amid Donald Trump’s threats of sweeping trade tariffs. Evening Standard · Apr 30, 2025
Drugs giant GSK ‘well positioned’ to absorb potential US tariffs It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines. Evening Standard · Apr 30, 2025
Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS? TRUMP TARIFFS: UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports The Independent UK · Apr 17, 2025
EU drug companies warn of exodus to US as Trump threatens import tariffs Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’ The Guardian - UK · Apr 9, 2025
Trump tariffs: Which UK sectors will be hit hardest? The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households. Evening Standard · Apr 3, 2025
Shingles vaccine tied to a 20% lower risk of dementia among older people The findings add to a growing body of evidence that the shingles vaccine may help keep dementia at bay – but researchers still need to prove it. Euronews · Apr 2, 2025
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt Emma Walmsley says her "180" would probably tell her to say "thank yous" and "well dones." Fortune · Apr 2, 2025
The Independent UK · Mar 26, 2025 FDA approves new UTI antibiotic that may help patients with recurring infections A commercial launch of the antibiotic in the U.S. is planned during the second half of 2025
Medical Daily · Mar 26, 2025 New Antibiotics For UTI Gets FDA Approval- First In 30 Years The FDA has approved a new antibiotic, Gepotidacin (Blujepa), for treating uncomplicated urinary tract infections (UTIs) in women and girls aged 12 and older.
Fortune · Mar 24, 2025 From $6 billion unicorn to bankrupt cautionary tale: The story of 23andMe DNA testing company 23andMe was a white-hot Silicon Valley startup for years, and Anne Wojcicki was a celebrity CEO. But after going public, investors lost faith in the DNA testing company.
Evening Standard · Mar 19, 2025 Pfizer offloads final shares in Sensodyne maker Haleon Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.
The Independent UK · Mar 11, 2025 Doctors didn’t warn ‘deviant sexual behaviour’ was side effect of restless legs syndrome drug Patients claim GPs did not tell them about significant potential side effects of treatment
Fortune · Mar 8, 2025 Power Players: Meet the women reshaping 10 key European industries This year, Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.
Fortune · Mar 1, 2025 23andMe was once worth $6 billion. Now CEO Anne Wojcicki wants to buy it back for $42 million Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags.
The Guardian - UK · Feb 28, 2025 British pharma company GSK pauses diversity work citing Trump orders London-based FTSE 100 firm reviewing its policies, saying it is obliged to comply because US is its No 1 market
Fortune · Feb 28, 2025 GSK could double CEO Emma Walmsley's pay to $27 million The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.
The Guardian - UK · Feb 27, 2025 GSK boss Emma Walmsley’s pay could rise to nearly £22m in three years’ time UK pharmaceutical companies aim to put executive pay on par with US rivals’ but package will depend on share price
The Guardian - UK · Feb 25, 2025 Women hold almost 45% of seats on FTSE 100 boards, report says New high tempered by dip in number of female CEOs at 100 biggest listed firms to fewer than 10 last year